| The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts Experts in Chronic Myeloid Leukemia Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013 | 689 | 2013 |
| Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis HM Kantarjian, TP Hughes, RA Larson, DW Kim, S Issaragrisil, ... Leukemia 35 (2), 440-453, 2021 | 218 | 2021 |
| Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study M Conchon, SS Sanabani, I Bendit, FM Santos, M Serpa, ... Journal of Hematology & Oncology 2, 1-4, 2009 | 104 | 2009 |
| Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) by real-time quantitative … H Pfeifer, G Cazzaniga, VHJ Van der Velden, JM Cayuela, B Schäfer, ... Leukemia 33 (8), 1910-1922, 2019 | 70 | 2019 |
| Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. M Novaes, I Bendit, B Garicochea, A Del Giglio Molecular Pathology 50 (4), 209, 1997 | 69 | 1997 |
| Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis MF Bezerra, AS Lima, MR Piqué-Borràs, DR Silveira, JL Coelho-Silva, ... Blood, The Journal of the American Society of Hematology 135 (11), 870-875, 2020 | 68 | 2020 |
| Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy M Conchon, SS Sanabani, M Serpa, MMY Novaes, L Nardinelli, ... Advances in Hematology 2010, 2010 | 66 | 2010 |
| Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale NCP Cross, HE White, T Ernst, L Welden, C Dietz, G Saglio, FX Mahon, ... Leukemia 30 (9), 1844-1852, 2016 | 58 | 2016 |
| Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET) J Cortes, C De Souza, M Ayala‐Sanchez, I Bendit, C Best‐Aguilera, ... Cancer 116 (21), 4991-5000, 2010 | 54 | 2010 |
| Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale HE White, J Hedges, I Bendit, S Branford, D Colomer, A Hochhaus, ... Clinical chemistry 59 (6), 938-948, 2013 | 50 | 2013 |
| Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised … JE Cortes, CA De Souza, M Ayala, JL Lopez, E Bullorsky, S Shah, ... The Lancet Haematology 3 (12), e581-e591, 2016 | 45 | 2016 |
| Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results TP Hughes, B Leber, F Cervantes, N Spector, R Pasquini, ... Leukemia 31 (11), 2529-2531, 2017 | 40 | 2017 |
| Long-term outcomes in patients with chronic myeloid leukemia in chronic phase receiving frontline nilotinib versus imatinib: ENESTnd 10-year analysis TP Hughes, G Saglio, RA Larson, HM Kantarjian, DW Kim, S Issaragrisil, ... Blood 134, 2924, 2019 | 37 | 2019 |
| Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia MRM de Conchon, JL Costa, MMY Novaes, PE Dorlhiac-Llacer, ... International journal of hematology 88, 243-245, 2008 | 37 | 2008 |
| CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy AR Manhani, R Manhani, HP Soares, I Bendit, F Lopes, AGB Nicoletti, ... Breast cancer research and treatment 66, 249-254, 2001 | 35 | 2001 |
| Molecular and immunohistochemical analysis of P53 in phaeochromocytoma PLM Dahia, RCT Aguiar, AM Tsanaclis, I Bendit, SP Bydlowski, ... British journal of cancer 72 (5), 1211-1213, 1995 | 35 | 1995 |
| Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms A Didone, L Nardinelli, M Marchiani, ARL Ruiz, AL de Lima Costa, ... Practical laboratory medicine 4, 30-37, 2016 | 33 | 2016 |
| Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities AC Da Costa, I Bendit, ACS De Oliveira, EG Kallas, EC Sabino, ... Clinical Microbiology and Infection 19 (1), E31-E43, 2013 | 30 | 2013 |
| N‐myc oncogene expression and amplification in metastatic lesions of stage IV‐S neuroblastoma J Garvin Jr, I Bendit, PD Nisen Cancer 65 (11), 2572-2575, 1990 | 30 | 1990 |
| Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic … VM Rezende, A Rivellis, MMY Novaes, D de Alencar Fisher Chamone, ... Drug design, development and therapy, 699-710, 2013 | 29 | 2013 |
KATIA BORGIA BARBOSA PAGNANOCentro de Hematologia e Hemoterapia (HEMOCENTRO) - Universidade Estadual de Campinas (UNICAMP)E-mail confirmado em unicamp.br
